Baidu
map
PLOS BIOL 润色咨询

PLOS BIOLOGY

出版年份:2003 年文章数:4263 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2024-03-23 无为而无不为 来自浙江省

    偏重的研究方向:分子生物学;生化
    经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2024-09-02 无为而无不为 来自浙江省

    继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2023-01-30 ms9000000620079135 来自广东省

    With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2022-06-21 mltt

    审稿速度:12.0 | 投稿命中率:25.0
    经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2022-11-19 slientwo

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:生物学
    经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    讨论中第一段一定要撰写文章的总括么?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    什么叫有深度的讨论/如何加深讨论深度?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2021-05-29 123b4422m94(暂无昵称)

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:生物学;分子生物学
    经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2018-08-06 chenweilong

    我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^mengsxl 2012-07-24 16:08:00 发表:
    额,这么牛差

    ---------------------------
    引用经验:
    退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿

    mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差

    ---------------------------
    引用经验:
    退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2194818, encodeId=9b7221948188a, content=偏重的研究方向:分子生物学;生化<br>经验分享:投稿时需要同时上传原始胶图以及统计数据,目前editor手上快一周了,希望能送审,继续分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Sat Mar 23 08:09:20 CST 2024, time=2024-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223727, encodeId=60f62223e27dc, content=继续分享,投稿两个月后一审回来,补实验三个月,中间又多申请延长了一个月,刚补完,投回去,希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/2ec953b39d0c4bbe8fb85a3ecce1285a/ba37c407d854460daaff4164abd9b302.jpg, createdBy=99242317671, createdName=无为而无不为, createdTime=Mon Sep 02 19:28:51 CST 2024, time=2024-09-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112067, encodeId=bae0211206e7b, content=With Editor小一周了,编辑处理稿件好慢,已经准备好收到拒信了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cfb5496474, createdName=ms9000000620079135, createdTime=Mon Jan 30 01:12:24 CST 2023, time=2023-01-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1227776, encodeId=4dcd122e7761f, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享:突然才发现该杂志2021年300多篇文章,只有2篇综述,影响因子如果今年能上10或者接近10的话,能一定程度说明文章质量过硬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8cc71740552, createdName=mltt, createdTime=Tue Jun 21 15:59:21 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101456, encodeId=343f2101456d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学<br>经验分享:是Plos系列创刊的第一个杂志,也是Plos出版社flagship杂志,在2013年时候影响因子有15分左右,现在影响因子下降了,但杂志在业内仍然具有很大的影响力。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Nov 19 08:52:01 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099278, encodeId=de6b10992e8c3, content=讨论中第一段一定要撰写文章的总括么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099277, encodeId=6d5710992e7a4, content=什么叫有深度的讨论/如何加深讨论深度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969387, encodeId=5bfe96938e69, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:生物学;分子生物学<br>经验分享:editor很nice,杂志有专门的academic reviewer。沟通很及时,有一定的创新性和数据值得尝试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93082430063, createdName=123b4422m94(暂无昵称), createdTime=Sat May 29 09:51:07 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559903, encodeId=99d455990387, content=我2018年投的时候感觉编辑很nice呀。可能后来换了个亲和的editor了^-^<span class="quote">mengsxl 2012-07-24 16:08:00 发表:<br>额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿</span> <br></span>, beContent=mengsxl 2012-07-24 16:08:00 发表: 额,这么牛差<br><br>---------------------------<br> <b>引用经验:</b><br> <span class="reply_node">退稿率90%以上,一般的成果不要投了,我同实验室的文章以前被编辑回信挖苦过,编辑说这样的数据浪费他时间去审稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Mon Aug 06 00:00:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559194, encodeId=ece75591949c, content=总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-<span class="quote">chenweilong 2018-06-27 00:00:00 发表:<br>用谷歌浏览器可以正常打开(网速还可以的话).</span>, beContent=chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话)., objectType=tool_impact_factor, channel=null, level=null, likeNumber=562, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/29/6566d3ba9f44e0ed586bf56437c16db3.jpg, createdBy=24c12049526, createdName=chenweilong, createdTime=Sat Jul 14 00:00:00 CST 2018, time=2018-07-14, status=1, ipAttribution=)]
    2018-07-14 chenweilong

    总体感觉.PLOS Biology编辑团队效率很高. 投的肿瘤生物学领域的研究.一审一个月收到回信major revision.花两个月revision再投回去, 一个月后收到了邮件.minor revision.花一个月.修稿返回, 一周后左右.final revision.最后接受, 编辑很nice.发过去的邮件基本都能收到编辑的及时回复(要注意时差问题哦), 审稿挺严格的.另外.PLOS Biology是OA(open access)期刊(事实上整个PLOS系统都是OA).便于读者阅读.这一点还是值得肯定的. 想投的话.加油!大胆一些!祝顺利-chenweilong 2018-06-27 00:00:00 发表:
    用谷歌浏览器可以正常打开(网速还可以的话).

    chenweilong 2018-06-27 00:00:00 发表: 用谷歌浏览器可以正常打开(网速还可以的话).

    0

共35条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map